{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:34:18Z","timestamp":1795005258044,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"name":"Japan Society for the Promotion of Science","award":["23K27495"],"award-info":[{"award-number":["23K27495"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Japan Society for the Promotion of Science","award":["24K12061"],"award-info":[{"award-number":["24K12061"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>\n                      Thromboxane A\n                      <jats:sub>2<\/jats:sub>\n                      (TXA\n                      <jats:sub>2<\/jats:sub>\n                      ), a metabolite of arachidonic acid, is well known for its role in vasoconstriction and platelet aggregation via activation of thromboxane prostanoid receptors (TPR). Although other prostanoid receptors have established roles in pain modulation, the contribution of TXA\n                      <jats:sub>2<\/jats:sub>\n                      -TPR signaling to nociceptive processing remains unclear. This study evaluated the analgesic effects of a TPR agonist in mouse models of pain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Four-week-old male ddY mice, an outbred mouse strain, received intrathecal (i.t.) administration of (Z)-7-((1S,2R,3R,4R)-3-((R,E)-3-hydroxy-4-(4-iodophenoxy)but-1-en-1-yl)-7-oxabicyclo[2.2.1]heptan-2-yl)hept-5-enoic acid (I-BOP), a TPR agonist, in four pain models (n = 6\u201310 per group): hot plate test, formalin test, prostaglandin E\n                      <jats:sub>2<\/jats:sub>\n                      (PGE\n                      <jats:sub>2<\/jats:sub>\n                      )-induced allodynia, and L5 spinal nerve transection (L5-SNT). Behavioral tests evaluated pain responses as the primary outcome. The mRNA expression levels of cyclooxygenase (COX)-1, COX-2, TXA\n                      <jats:sub>2<\/jats:sub>\n                      synthase (TXAS), and TPR were analyzed by reverse transcription-polymerase chain reaction and compared between ipsilateral and contralateral L4\u2013L6 spinal dorsal horns. TPR localization in the spinal dorsal horn was determined by immunohistochemistry. Data were analyzed using appropriate parametric or nonparametric tests based on the results of normality assessment. Comparisons between groups were performed using Student t test, the Mann\u2013Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test, 1-way analysis of variance (ANOVA) with Dunnett post hoc test, 2-way ANOVA with Bonferroni post hoc test, or Friedman test followed by Wilcoxon signed-rank tests with Bonferroni correction as appropriate. All behavioral assessments were conducted in a blinded manner.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      In the PGE\n                      <jats:sub>2<\/jats:sub>\n                      -induced allodynia model, coadministration of I-BOP dose dependently reduced the allodynia score compared with PGE\n                      <jats:sub>2<\/jats:sub>\n                      alone. When the response to PGE\n                      <jats:sub>2<\/jats:sub>\n                      alone was defined as 100%, the allodynia scores were reduced to 20% (95% confidence interval [CI], \u22127 to 47;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0012) at 1 ng and 10% (95% CI, \u221211 to 31;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) at 10 ng I-BOP. In the L5-SNT neuropathic pain model, i.t. I-BOP produced a dose-dependent elevation of mechanical withdrawal thresholds, with significant main effects of dose (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and a significant dose \u00d7 time interaction (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0012). In the formalin test, I-BOP selectively reduced nociceptive behavior during the second phase (I-BOP 140 \u00b1 6.2 seconds; saline 623 \u00b1 18.1 seconds, expressed as mean \u00b1 standard error of the mean [SEM];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .008), without affecting the first phase. The ipsilateral spinal dorsal horn of L5-SNT mice showed increased TPR mRNA expression. Immunohistochemistry revealed TPR localization in both the substantia gelatinosa and deep laminae of the spinal dorsal horn.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>These findings suggest that a TPR agonist exerts analgesic effects by acting on TPR expressed in the spinal cord, highlighting the potential role of TPR signaling in pain modulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000008045","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:00:10Z","timestamp":1777064410000},"page":"897-906","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Analgesic Effect of a Thromboxane A2 Receptor Agonist on Multiple Pain Models in Mice"],"prefix":"10.1213","volume":"143","author":[{"given":"Atsushi","family":"Fujiwara","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Kansai Medical University, Hirakata, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/glia.21090","article-title":"A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.","volume":"59","author":"Kunori","year":"2011","journal-title":"Glia"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/bpb.34.1170","article-title":"Prostaglandin E2 and pain.","volume":"34","author":"Kawabata","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs.","volume":"104","author":"Vane","year":"1998","journal-title":"Am J Med"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-0102(01)00289-9","article-title":"Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociception and nocistatin.","volume":"41","author":"Ito","year":"2001","journal-title":"Neurosci Res"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions.","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol Rev"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3959(94)90226-7","article-title":"Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice.","volume":"57","author":"Minami","year":"1994","journal-title":"Pain"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3959(92)90166-9","article-title":"Allodynia evoked by intrathecal administration of prostaglandin F2a to conscious mice.","volume":"50","author":"Minami","year":"1992","journal-title":"Pain"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(90)90723-O","article-title":"Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2\u03b1 to conscious mice.","volume":"510","author":"Uda","year":"1990","journal-title":"Brain Res"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1476-5381.1994.tb13139.x","article-title":"Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.","volume":"112","author":"Minami","year":"1994","journal-title":"Br J Pharmacol"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001756-200201210-00022","article-title":"Central nociceptive role of prostacyclin (IP) receptor induced by peripheral inflammation.","volume":"13","author":"Doi","year":"2002","journal-title":"Neuroreport"},{"key":"R11-20260915","first-page":"88","article-title":"Cellular activation by thromboxane A2 and other eicosanoids.","volume":"14","author":"Reilly","year":"1993","journal-title":"Eur Heart J"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals.","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.bjp.0704092","article-title":"Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.","volume":"133","author":"Minami","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain.","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1046\/j.1460-9568.1999.00602.x","article-title":"Involvement of primary afferent C-fibers in touch-evoked pain (allodynia) induced by prostaglandin E2.","volume":"11","author":"Minami","year":"1999","journal-title":"Eur J Neurosci"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00540-020-02762-2","article-title":"Stiripentol alleviates neuropathic pain in L5 spinal nerve-transected mice.","volume":"34","author":"Fujiwara","year":"2020","journal-title":"J Anesth"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw.","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuroscience.2009.05.069","article-title":"Involvement of prostaglandin F2a receptor in ATP-induced mechanical allodynia.","volume":"163","author":"Kunori","year":"2009","journal-title":"Neuroscience"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1365-2044.2010.06542.x","article-title":"The analysis of variance in anaesthetic research: statistics, biography and history.","volume":"65","author":"Pandit","year":"2010","journal-title":"Anaesthesia"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0306-4522(97)00258-3","article-title":"Calcitonin gene-related peptide increase in the rat spinal dorsal horn and dorsal column nucleus following peripheral nerve injury: up-regulation in a subpopulation of primary afferent sensory neurons.","volume":"82","author":"Miki","year":"1998","journal-title":"Neuroscience"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1016\/S0021-9258(18)31586-2","article-title":"The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family.","volume":"266","author":"Shenker","year":"1991","journal-title":"J Biol Chem"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/glia.22487","article-title":"Cox-1-dependent prostaglandin D2 in microglia contributes to neuropathic pain via DP2 receptor in spinal neurons.","volume":"61","author":"Kanda","year":"2013","journal-title":"Glia"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejpain.2008.09.001","article-title":"Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice.","volume":"13","author":"Popp","year":"2009","journal-title":"Eur J Pain"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1213\/01.ANE.0000130351.76523.3F","article-title":"Local anesthetics inhibit thromboxane A2 signaling in Xenopus oocytes and human k562 cells.","volume":"99","author":"H\u00f6nemann","year":"2004","journal-title":"Anesth Analg"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"37104","DOI":"10.1038\/srep37104","article-title":"Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain.","volume":"6","author":"Imlach","year":"2016","journal-title":"Sci Rep"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-3565(25)20764-9","article-title":"Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.","volume":"278","author":"Minami","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1523\/JNEUROSCI.3923-08.2009","article-title":"Glycine inhibitory dysfunction induces a selectively dynamic, morphine resistant, and neurokinin 1 receptor-independent mechanical allodynia.","volume":"29","author":"Miraucourt","year":"2009","journal-title":"J Neurosci"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10815-018-1159-8","article-title":"Platelet-rich plasma therapy and reproductive mesicine.","volume":"35","author":"Bos-Mikich","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"23259671221140888","DOI":"10.1177\/23259671221140888","article-title":"Update on the use of platelet-rich plasma injections in the management of musculoskeletal injures: a systematic review of studies from 2014 to 2021.","volume":"10","author":"O\u2019Dowd","year":"2022","journal-title":"Orthop J Sports Med"},{"key":"R31-20260915","first-page":"465","article-title":"Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: an umbrella review.","volume":"17","author":"Cruciani","year":"2019","journal-title":"Blood Transfus"}],"updated-by":[{"DOI":"10.1213\/ane.0000000000008374","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000}}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:00:21Z","timestamp":1789513221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000008045","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}